logo
news

Clinical Update | Ileus Tube Sets for Adhesive Small Bowel Obstruction: Clinical Outcomes and Efficacy

July 2, 2026

Adhesive small bowel obstruction (ASBO) is a common cause of acute abdomen, primarily resulting from postoperative intra-abdominal adhesions. Conventional nasogastric decompression is often insufficient for distal small bowel drainage, leading to delayed symptom resolution and prolonged hospitalization.

This study evaluated the clinical efficacy and safety of the Ileus Tube Sets in comparison with standard nasogastric tube decompression in patients with ASBO.

Methods

A randomized controlled study was conducted at Jiangxi Provincial People's Hospital between March 2022 and February 2024.

A total of 116 patients diagnosed with adhesive small bowel obstruction were enrolled and randomly assigned into two groups:

Outcome Measures

Primary and secondary endpoints included:

Intervention

Nasogastric Tube Decompression (Control Group)

A standard nasogastric tube was inserted via the nasal cavity into the stomach for gastrointestinal decompression. This approach primarily decompresses the stomach and proximal intestine but has limited effect on distal small bowel obstruction.

Ileus Tube Sets Decompression (Observation Group)

Under fluoroscopic guidance, a 300 cm Ileus Tube Sets was advanced beyond the pylorus into the duodenum and jejunum.

The system utilizes:

This allows direct decompression of the proximal obstructed bowel segment.

Results

1. Overall Clinical Efficacy

The Ileus Tube Sets group demonstrated a significantly higher total effective rate compared with the control group (P < 0.05).

2. Faster Gastrointestinal Recovery

Patients in the observation group showed:

3. Reduced Hospital Length of Stay

4. Improved Decompression Efficiency

The observation group showed significantly higher mean daily drainage volume:

5. Lower Complication Rate

Reported adverse events included:

Discussion

Adhesive small bowel obstruction remains a challenging clinical condition with significant morbidity. While nasogastric decompression remains the first-line conservative treatment, its limited reach to the distal small bowel reduces its effectiveness in severe cases.

The Ileus Tube Sets provides a significant therapeutic advantage due to:

These mechanisms collectively contribute to faster symptom resolution, improved gastrointestinal recovery, and reduced hospitalization time.

Clinical Implications

The findings suggest that the Ileus Tube Sets may offer a superior non-surgical alternative for managing adhesive small bowel obstruction, with improved efficacy and safety compared to conventional nasogastric decompression.

It may be considered as a preferred decompression strategy in selected patients with ASBO, particularly those with persistent or distal obstruction.

Conclusion

In patients with adhesive small bowel obstruction, the Ileus Tube Sets significantly improves clinical outcomes compared with standard nasogastric tube decompression.

It enhances overall treatment efficacy, accelerates gastrointestinal recovery, reduces hospital length of stay, and lowers complication rates.

These results support the Ileus Tube Sets as a promising and potentially preferred conservative treatment option for adhesive small bowel obstruction.